Just doubled my small investment in $SRNA this morning. This little dip before the report comes out seems like the perfect time to get some cheap shares before more people start to realize that there is a real potential for profitability with this company. The lucrative Beta test deal with the Nevada company sounds great considering it's just a Beta test. When that system proves itself and they have a chance to work out the bugs and perfect the design, it should be a lot easier to make more such lucrative deals with other large growers. Making that deal with the first company was a big accomplishment in my eyes, and that's what led me to hang on to my small amount of shares even while the PPS has been sliding down slowly. Eventually when good enough numbers come out, this downslide could turn around pretty suddenly. Not sure if it'll be this report or the next though. We shall see. But I'm glad I'm into $SRNA a little deeper now, and watching it more closely now.